Cargando…
Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event
INTRODUCTION AND OBJECTIVE: The potential of metamizole to cause drug-induced liver injury (DILI) has received increasing attention. We investigated the distinguishing features of a case series comprising 32 patients with suspected metamizole-induced DILI. METHODS: For the current analysis, 32 of 23...
Autores principales: | Weber, Sabine, Benesic, Andreas, Neumann, Jens, Gerbes, Alexander L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184550/ https://www.ncbi.nlm.nih.gov/pubmed/33638811 http://dx.doi.org/10.1007/s40264-021-01049-z |
Ejemplares similares
-
Drug‐Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment Tool
por: Weber, Sabine, et al.
Publicado: (2020) -
Metamizole-Associated Adverse Events: A Systematic Review and Meta-Analysis
por: Kötter, Thomas, et al.
Publicado: (2015) -
Proteomics Analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by Diclofenac
por: Dragoi, Diana, et al.
Publicado: (2018) -
Drug-induced liver injury: recent advances in diagnosis and risk assessment
por: Kullak-Ublick, Gerd A, et al.
Publicado: (2017) -
Metamizole as a Rare Cause of Drug-Induced Liver Injury
por: Preveden, Nevena, et al.
Publicado: (2022)